Starpharma Holdings Ltd
OTC:SPHRF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Starpharma Holdings Ltd
OTC:SPHRF
|
AU |
|
K
|
Kinder Morgan Inc
F:2KD
|
US |
|
BREMER LAGERHAUS-GESELLSCHAFT AG von 1877
F:BLH
|
DE |
|
B
|
Basellandschaftliche Kantonalbank
SIX:BLKB
|
CH |
Intrinsic Value
Is SPHRF undervalued or overvalued?
See the intrinsic value estimate for 
Starpharma Holdings Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
SPHRF looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with SPHRF’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Starpharma Does
Starpharma Holdings Ltd is a biotechnology company that develops and commercializes dendrimer-based products. Its best-known products are its antiviral and antibacterial gels and coatings, including women’s health products and disinfectant or surface-treatment technologies. In simple terms, it uses its chemistry platform to make products that can block germs or carry active ingredients in a more targeted way.
- Headquarters
- Australia AU
- Employees
- 50
- IPO date
- Sep 28, 2000
Earnings Waterfall
Starpharma Holdings Ltd
The intrinsic value for Starpharma Holdings Ltd (SPHRF) under the Base Case is hidden USD.
Compared with the current market price of 0.58 USD, the stock appears hidden.